Skip to main content

Table 3 Treatment of cells in different groups

From: A novel Bursin-like peptide as a potential virus inhibitor and immunity regulator in SPF chickens infected with recombinant ALV

Group

ALV/placebo Dosage

BLP/placebo Dosage

Action Phase

Cell Control (CC)

DMEM

N

N

ALV Control (AC)

5 × 104 TCID50

N

N

ALV + BL21 supernatant (AS)

5 × 104 TCID50

purified BL21 culture

2 h after ALV infection

ALV + BLP (AB)

5 × 104 TCID50

50 μg purified BLP

2 h after ALV infection

BLP + ALV (BA)

5 × 104 TCID50

50 μg purified BLP

2 h before ALV infection

ALV and BLP together (A&B)

5 × 104 TCID50

50 μg purified BLP

Together with ALV infection